PARASOL Project Advances Understanding of Proteinuria in FSGS
BETHESDA, Md. October 14, 2024 – A multi-stakeholder group of rare kidney disease experts ...
PARASOL Interim Meeting Report
After a successful meeting in December 2023 to launch the PARASOL initiative, the group ...
NEJM "Science behind the Study" Editorial: Kidney Disease and Antinephrin Antibodies
Don't miss the new "Science behind the Study" editorial by Jochen Reiser, MD, PhD ...
Anti-nephrin autoantibodies in minimal change disease and idiopathic NS
New research demonstrates role of anti-nephrin autoantibodies as causative factor and ...
FSGS and NS Research Funding Opportunities Through PRMRP
The US Department of Defense includes FSGS and nephrotic syndrome as two of the priority ...
ISGD President Tobias B. Huber Awarded Prestigious ERC Advanced Grant to Study FSGS
Professor Dr. Tobias B. Huber, the inaugural President of the International Society of ...
New Era Act Introduced in Congress
We are thrilled to share that the New Era of Preventing End-Stage Kidney Disease Act ...
Announcing the PARASOL Project: PROTEINURIA AND GFR AS CLINICAL TRIAL ENDPOINTS IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS
ISGD is collaborating in a multidisciplinary effort to tackle the urgent problem of ...
EXPLORING THE NICHE: GLOMERULAR DISEASE MANAGEMENT IN NEPHROLOGY
Navigating the complexities of glomerular diseases (GD) in nephrology is no small feat. ...
Addressing the Unequal Burden of Kidney Disease on Black Americans
As kidney specialists, I'm sure we all know the statistic that chronic kidney disease is ...